Loading...
Last update:  October 15, 2017
12:47 +1GMT

Allergenic Molecule  Act d 11Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
4.1.6 - Heterologous Source Sensitized (High IgE)2011AustriaIgE6033.33020110211, DAvino R
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE224.55020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2020.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3721.62020090826, Ebo DG
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9919.19020110223, De Knop KJ
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1000.00020111214, Zheng YW
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1405.00020130111, Ott H
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2015.00020091005, Ott H
3.2.1 - Source Sensitized (IgE)2013ItalyIgE2847.75020130420, Palazzo P
3.2.1 - Source Sensitized (IgE)2011ItalyIgE83513.77020110211, DAvino R
4.1.5 - Heterologous Source Sensitized (IgE)2011ItalyIgE108410.51020110211, DAvino R
4.1.6 - Heterologous Source Sensitized (High IgE)2011ItalyIgE21428.50020110211, DAvino R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013ItalyIgE360.00020130420, Palazzo P
3.1.4 - Source Sensitized (SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE1983.54020101118, Bublin M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE23710.13020101118, Bublin M
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE553.60020120726, Pedrosa M
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2012SpainIgE682.90020120726, Pedrosa M
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE960.00020120528, Patelis A
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
Developed by
Panservice